Wed.May 22, 2024

article thumbnail

5 Things to Know About the Sorry State of Healthcare Cybersecurity

MedCity News

During a fireside chat at MedCity News’ INVEST conference, Nitin Natarajan — deputy director at the Cybersecurity and Infrastructure Security Agency (CISA) — shared some key ideas that people need to understand about the current state of cybersecurity in the healthcare industry. For instance, he reminded us that things won’t get better overnight, and that cybersecurity requires an all-hands-on deck approach.

article thumbnail

Pfizer, busy with $4B savings drive, plots even more cuts out to 2027

Fierce Pharma

Pfizer has made frequent headlines in recent months as it moves forward with a campaign to save $4 billion in annual costs by the end of this year. | Pfizer has made frequent headlines in recent months as it moves forward with a campaign to save $4 billion in annual costs by the end of this year. Now, the company has unveiled another savings drive that will run longer.

273
273
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Allying With Patients to Make Every Cure Possible

MedCity News

To win the battle against rare diseases, drug developers must work hand-in-hand with patients. The post Allying With Patients to Make Every Cure Possible appeared first on MedCity News.

Patients 287
article thumbnail

Otsuka pulls plug on Alzheimer's agitation drug after 2nd failed trial

Fierce Pharma

Otsuka Pharmaceutical is packing up an Alzheimer’s disease med after a phase 3 study failed to move the needle on m | Otsuka Pharmaceutical is packing up an Alzheimer’s disease med after a phase 3 study failed to move the needle on measures of agitation associated with dementia.

article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

What Frustrates 3 Women’s Health Execs

MedCity News

There have been several advancements in the women’s health space, but we still have a long way to go, execs said during a recent panel. The post What Frustrates 3 Women’s Health Execs appeared first on MedCity News.

278
278

More Trending

article thumbnail

Biogen Immunology Strategy Comes Into Focus With $1B HI-Bio Acquisition

MedCity News

Biogen’s acquisition of Human Immunology Biosciences brings a drug candidate with potential applications in multiple immune-mediated disorders. The deal comes just prior to the scheduled presentation of clinical data in two of them. The post Biogen Immunology Strategy Comes Into Focus With $1B HI-Bio Acquisition appeared first on MedCity News.

Biopharma 274
article thumbnail

ASCO: Data detail Verzenio's flop in prostate cancer as Lilly seeks redemption via radiotherapy

Fierce Pharma

Eli Lilly has in the past few months unveiled two back-to-back trial flops for Verzenio in prostate cancer. Now, we know exactly how one sputtered. | Eli Lilly recently unveiled two back-to-back trial flops for Verzenio in prostate cancer. Now, we know exactly how one sputtered.

216
216
article thumbnail

Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work?

PharmaVoice

Direct-to-consumer platforms offer consumers an online path to sourcing popular medications, but some therapeutic areas may be better suited for the business model.

Marketing 162
article thumbnail

Bristol Myers lines up Opdivo treatment in Pakistan, Rwanda and beyond as part of 10-year access campaign

Fierce Pharma

When it comes to supporting cancer care and other therapeutic approaches in low- and middle-income countries (LMICs), Bristol Myers Squibb is taking a long-term view. | In its quest to reach more than 200,000 patients with its medicines in low- and middle-income countries by 2033, BMS is embarking on a 10-year access effort.

Medicine 191
article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Journey From Physical Therapy To Health Tech Sales And AI Innovation With Cory Hutchins

Evolve Your Success

When Cory Hutchins swapped the physical therapy clinic for the dynamic world of health tech sales, he didn’t just change careers—he transformed his entire life. Our latest episode shines a spotlight on Cory’s inspiring story, as he shares the rich details of his transition supported by the Medical Sales Career Builder program. Discover how he now excels as a Sales Development Representative at WebPT, where his love for technology and clinical acumen converge to empower medical p

Sales 130
article thumbnail

Merck KGaA unit avoids DOJ prosecution after exposing scheme to divert drugs to China

Fierce Pharma

Merck KGaA’s North American life science division, MilliporeSigma, has made U.S. | The U.S. Department of Justice on Wednesday announced that Florida residents Pen Yu, 51, and Gregory Muñoz, 45, each pleaded guilty to one count of wire fraud conspiracy for their roles in a scheme to “fraudulently procure deeply discounted products” from Merck KGaA's MilliporeSigma and export them to China using faked export documents.

184
184
article thumbnail

Drug shortages, cost concerns and iffy access — how DTC and telehealth could even the playing field

PharmaVoice

Companies like UpScriptHealth led the charge with online prescriptions decades ago, and now the industry is catching on to solve some of healthcare’s most pressing issues.

article thumbnail

Sanofi, Bristol Myers on the hook for $916M in do-over of Plavix marketing case in Hawaii

Fierce Pharma

Hawaii has ordered BMS and Sanofi to pay a $916M for failing to warn about the potential ineffectiveness of blood thinner Plavix in some patients.

Marketing 179
article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

New ‘plug and play’ system to offer novel way of delivering vaccines and treatments

PharmaTimes

The nanocage technology combines both mRNA and traditional virus-based vaccines to create virus-like efficacious vaccines

120
120
article thumbnail

Tony Blair Institute weighs in on use of NHS patient data

pharmaphorum

A think tank set up by former UK Prime Minister Tony Blair has called for the formation of a public-private trust that could oversee the sharing of anonymised patient data with trusted researchers.

Patients 115
article thumbnail

UK lung cancer study demonstrates further evidence on importance of CT screening

PharmaTimes

Currently the third most common cancer in the UK, lung cancer affects 40,000 people annually

119
119
article thumbnail

US senators accuse pharma firms of abusing patent system

pharmaphorum

Lawmakers across the political divide have accused the pharma industry of abusing the patent system to keep the prices of their products as high as possible.

Pharma 115
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

Bristol Myers Squibb Plans 10-Year Strategy to Expand Access to Medications

PharmaTech

The company is collaborating with the Access to Oncology Medicines Coalition to expand patient access to immuno-oncology therapy Opdivo.

Medical 111
article thumbnail

GSK’s twice-yearly asthma drug clears two phase 3 trials

pharmaphorum

GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new IL-5 inhibitor depemokimab (formerly GSK3511294) has the potential to become the first ultra-long-acting biologic for severe asthma with a six-monthly dosing schedule.

111
111
article thumbnail

Pharma Pulse 5/22/24: A Pharmacist’s Impact on Inclusive Health Care, ChatGPT Usage to Support Drug Development & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 104
article thumbnail

Click buys Better assets to speed its digital obesity drive

pharmaphorum

Digital health firm Click Therapeutics has bought the assets of Better Therapeutics to speed up development of a prescription digital therapeutic for obesity

article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

European Commission grants first-of-a-kind biosimilar approval

European Pharmaceutical Review

The European Commission (EC) has approved the first and only biosimilar versions of the reference medicines Xgeva ® and Prolia ® in Europe. Sandoz shared that Wyost ® (denosumab) is approved for treating cancer-related bone disease. Jubbonti ® (denosumab) is authorised as an osteoporosis treatment. The decision by the EC “is a major step in advancing the Sandoz growth strategy”, the company asserted.

article thumbnail

Immune checkpoint enhancer biotech AltruBio raises $225m

pharmaphorum

Immune checkpoint enhancer biotech AltruBio raises $225m to support phase 2 trials of its PSGL-1-targeted drug for ulcerative colitis

105
105
article thumbnail

No nitrosamines: How parenteral packaging is evolving to meet today’s E&L challenges

Pharmaceutical Technology

As the nitrosamine scandal continues, we explore the advancements in parenteral packaging materials that are reducing the risk of this contaminant in modern injectables.

97
article thumbnail

Mission Critical: Society Publishing in an Open Access World

Copyright Clearance Center

The post Mission Critical: Society Publishing in an Open Access World appeared first on Copyright Clearance Center.

75
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

[Podcast] Is Your Healthcare Email Marketing HIPAA Compliant?

Healthcare Success

Is your email marketing HIPAA compliant? Do you have adequate encryption at every step? Are you sure? Remember, even a patient’s email address could be considered PHI if linked to a health condition or treatment. If you are suddenly feeling a little uneasy, I promise you are not alone. Most healthcare marketers are unaware that seemingly innocuous patient email marketing campaigns are yet another area where you could inadvertently run afoul with HIPAA regulations, or, even worse, suffer a breach

article thumbnail

Judge says Ultragenyx must face Henrietta Lacks estate suit

pharmaphorum

An attempt by Ultragenyx to have a lawsuit filed by the family of Henrietta Lacks dismissed before it could be heard has failed. US District Judge Deborah Boardman turned down Ultragenyx’s request in a Baltimore federal court, concluding that the allegation that the company had profited from cells harvested from Lacks without her consent should be held up to scrutiny.

64
article thumbnail

Genmab acquires biotechnology company ProfoundBio in $1.8bn deal

Pharmaceutical Technology

Genmab has concluded the acquisition of ProfoundBio, a clinical-stage biotechnology company, in an all-cash transaction valued at $1.8bn.

59